|
Ortho Evra® statistics show that The Food and Drug Administration (FDA) has received 21 reports of life-threatening blood clots and other side effect risks. Approximately 4 million women have used the Ortho Evra® patch since it went on sale in 2002. FDA records show that 17 patch users between the ages of 17 and 30 have suffered fatal heart attacks, blood clots, or strokes since August of 2002.
Ortho Evra®, Johnson & Johnson's contraceptive patch, contains higher levels of a hormone known to cause blood clots than traditional birth control pills. The FDA said in November of 2005, that the new label for the patch will include information about the higher levels of estrogen. Women who use Ortho Evra® are exposed to almost 60 percent more estrogen than those who use the pill, but the birth control pills can contain a higher total amount of estrogen. The difference in exposure could be due to the delivery mechanism of the patch hormones and absorption into the body.
The FDA is currently studying various aspects of Ortho Evra®, including its side effects and overall safety. Please use our FDA Resources to stay current with the latest news and announcements.
If you or a loved one have used the Ortho Evra® birth control patch and have been injured, please contact us today using the form on the right or by calling us toll-free at 1 (866) 664-0400 for a FREE case review or to have your legal questions answered.
|
